Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 25:12:1437432.
doi: 10.3389/fpubh.2024.1437432. eCollection 2024.

A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI

Affiliations

A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI

Xiao-Yun Lin et al. Front Public Health. .

Abstract

Background: Currently, there is a lack of global or even country/regional level data on adolescent non-alcoholic fatty liver disease (NAFLD) prevalence. However, an evidenced dose-dependent relationship exists between body mass index (BMI) and the risk of NAFLD. We aim to estimate the global and regional prevalence of adolescent NAFLD and related non-alcoholic steatohepatitis (NASH) based on BMI.

Methods: Sigmoidal fitting curves were generated between BMI and the risk of NAFLD/NASH using the data extracted from the NHANES database. With global and regional BMI data from the NCD-RisC database, adolescent NAFLD/NASH prevalence was estimated at the international, regional, and country levels from 1975 to 2016. The prevalence of adolescent NAFLD/NASH from 2017 to 2030 was also forecasted.

Results: The mean NAFLD prevalence was 15.31, and 12.68%, while the mean NASH prevalence was 2.50, and 2.47%, in boys, and girls aged 12-18, respectively. For both boys and girls, NAFLD/NASH prevalence increased with increasing BMI, and age. The global prevalence of adolescent NAFLD/NASH has gradually increased in the period from 1975 to 2016 and will maintain a similar trend between 2017 and 2030. High-income Western Countries had higher adolescent NAFLD/NASH whereas South Asia and Sub-Saharan Africa exhibited relatively lower adolescent NAFLD/NASH prevalence. The estimated annual percentage change (EAPC) of NAFLD prevalence in boys ranged from 0.72% (age 18) to 1.16% (age 12) while that in girls ranged from 0.69% (age 18) to 0.92% (age 12). EAPC of NASH prevalence in boys ranged from 1.65% (age 18) to 1.77% (age 12), and in girls from 1.48% (age 18) to 1.68% (age 12).

Conclusion: The adolescent NAFLD/NASH prevalence increases year by year, and its burden varies significantly among different countries and regions. BMI is a precise predictor of NAFLD/NASH prevalence.

Keywords: body mass index; epidemiology; model simulation; non-alcoholic steatohepatitis; nonalcoholic fatty liver disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Algorithm of the study.
Figure 2
Figure 2
Fitting curves model the correlation between BMI and risk of NAFLD/NASH BMI and risk of NAFLD in boys (A) and girls (B); BMI and risk of NASH in boys (C) and girls (D).
Figure 3
Figure 3
Estimated global prevalence of NAFLD/NASH in adolescents from 1975 to 2030, stratified by age Estimated global prevalence of NAFLD in boys (A) and girls (B); Estimated global prevalence of NASH in boys (C) and girls (D).
Figure 4
Figure 4
Estimated mean of regional NAFLD/NASH prevalence in adolescents from 1975 to 2030 Estimated mean of regional NAFLD prevalence in boys (A) and girls (B); Estimated mean of regional NASH prevalence in boys (C) and girls (D).
Figure 5
Figure 5
Estimated mean prevalence of adolescent NAFLD/NASH at country or region level in 2016 Estimated mean prevalence of adolescent NAFLD at country or region level in boys (A) and girls (B); Estimated mean prevalence of adolescent NASH at country or region level in boys (C) and girls (D).

References

    1. Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. . Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. (2019) 69:2672–82. doi: 10.1002/hep.30251 - DOI - PubMed
    1. Abeysekera KWM, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J, et al. . Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. Lancet Gastroenterol Hepatol. (2020) 5:295–305. doi: 10.1016/S2468-1253(19)30419-4, PMID: - DOI - PMC - PubMed
    1. Sahota AK, Shapiro WL, Newton KP, Kim ST, Chung J, Schwimmer JB. Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018. Pediatrics. (2020) 146:e20200771. doi: 10.1542/peds.2020-0771, PMID: - DOI - PMC - PubMed
    1. Doycheva I, Watt KD, Alkhouri N. Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. Hepatology. (2017) 65:2100–9. doi: 10.1002/hep.29068, PMID: - DOI - PubMed
    1. Arshad T, Paik JM, Biswas R, Alqahtani SA, Henry L, Younossi ZM. Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016. Hepatol Commun. (2021) 5:1676–88. doi: 10.1002/hep4.1760 - DOI - PMC - PubMed

LinkOut - more resources